Clinically important change in the visual analog scale after adequate pain control

Area of Science:

• Emergency Medicine
• Pain Management
• Clinical Research

Background:

• The visual analog scale (VAS) is widely used to assess pain severity.
• Defining the minimum clinically important difference (MCID) for VAS is essential for interpreting treatment outcomes in clinical trials.
• Previous studies have not consistently established an MCID for VAS in the context of acute pain management.

Purpose of the Study:

• To determine the MCID for the VAS of pain severity.
• To measure the change in VAS associated with patients' perception of adequate pain control.
• To inform the design of future analgesic trials.

Main Methods:

• A prospective, observational study was conducted with adult emergency department patients experiencing acute pain.
• Patients rated pain severity on a 100-mm VAS at presentation and discharge.
• Patients reported on their willingness to accept analgesics and whether pain control was adequate at discharge.

Main Results:

• A mean VAS reduction of 30.0 mm was observed in patients who achieved adequate pain control (81% of participants).
• Patients with inadequate pain control experienced a mean VAS decrease of only 5.7 mm.
• Patients reporting adequate pain control had a mean discharge VAS of 31.3 mm, compared to 55.1 mm for those without.

Conclusions:

• A 30.0 mm decrease in VAS represents a clinically important difference in pain severity, reflecting patient-perceived adequate pain control.
• Using adequate analgesic control as a basis for MCID may be more appropriate for future analgesic trials than minimal detectable change.
• This study provides a validated MCID for VAS in acute pain settings, aiding in the interpretation of treatment efficacy.